ZinebAbdelkarimAmmousMD

Clinical Genetics

Physician

Dr. Ammous is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
315 Lehman Ave
C
Topeka, IN 46571
Phone+1 260-593-0108

Fax+1 260-593-0116

University of Miami/Jackson Health SystemResidency, Medical Genetics and Genomics, 2011 - 2013
Methodist Hospital (Houston)Residency, Surgery, 2009 - 2011
Weill Cornell Medical College in QatarClass of 2009

The REPLACE Registry for Cholbam® (Cholic Acid) Start of enrollment: 2017 Jul 10
Active, not recruiting
Roles: Contact

PubMed

15 citations
Pathogenic variants in SLF2 and SMC5 cause segmented chromosomes and mosaic variegated hyperploidy.
Laura J Grange, John J Reynolds, Farid Ullah, Bertrand Isidor, Robert F Shearer
Nature Communications. 2022-11-04
6 citations
A biallelic SNIP1 Amish founder variant causes a recognizable neurodevelopmental disorder.
Zineb Ammous, Lettie E. Rawlins, Hannah Jones, Joseph S Leslie, Olivia Wenger
Plos Genetics. 2021-09-27
16 citations
Bi-allelic CCDC47 Variants Cause a Disorder Characterized by Woolly Hair, Liver Dysfunction, Dysmorphic Features, and Global Developmental Delay.
Marie Morimoto, Helen Waller-Evans, Zineb Ammous, Xiaofei Song, Kevin A. Strauss
American Journal of Human Genetics. 2018-11-01

BridgeBio Pharma Announces Dosing of First Patient in Phase 1 Trial of BBP-671, a Potential Best-in-Class Treatment for Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA)August 18th, 2022